.png)
LUCENTIS Coding: Intravitreal Injections for Wet AMD and RVO
The chart below can serve as a helpful guide in addition to your own practice resources and expertise.
These codes are not all inclusive. Commercial payers as well as Medicare and Medicaid may choose to create their own temporary codes. This guide is provided for informational purposes only. Correct coding is the responsibility of the provider submitting a claim for the item or service. Please check with the payer to verify codes and special billing requirements. Genentech USA, Inc., makes no representation or guarantees concerning reimbursement or coverage for any service or item.
We know patient care is your primary concern. If you have questions about patients' coverage for LUCENTIS, you can contact LUCENTIS Access Solutions for help. Call 866-724-9394 from 6 AM to 5 PM PT, Monday to Friday, or click here.
LUCENTIS Access Solutions provides billing and coding information. However, LUCENTIS Access Solutions does not provide billing services or coding advice. Correct coding is the responsibility of the provider submitting a claim for the item or service. Please check with the payer to verify codes and special billing requirements.
Who is LUCENTIS for?
LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with Wet Age-Related Macular Degeneration (AMD) and Macular Edema Following Retinal Vein Occlusion (RVO).
What important safety information should I know about LUCENTIS?
LUCENTIS is a prescription medication given by injection into the eye, and it has side effects. Some LUCENTIS patients have had detached retinas and serious eye infections. LUCENTIS should not be used in patients who have an infection in or around the eye or are allergic to LUCENTIS or any of its ingredients. LUCENTIS patients have had increases in eye pressure within 1 hour of an injection. Serious side effects also include inflammation inside the eye, and rarely, problems related to the injection procedure, such as cataracts. Although not common, some LUCENTIS patients have had strokes or heart attacks. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should call or visit your eye doctor right away. Ask your doctor if you have questions or want more information.
For additional safety information, please talk to your doctor and see the LUCENTIS full prescribing information.
LUCENTIS® is a registered trademark and the Access Solutions logo and the Access Solutions Treatment made possible logo are trademarks of Genentech USA, Inc.
